(2R,3S,4S,6S)-6-(((2R,3S,4S,6S)-6-(((2R,3S,4S,6R)-6-(((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl acetate;(3?,5?,12?)-3-[(O-4-O-?cetyl-2,6-dideoxy-?-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-?-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-?-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide; 16'-Acetyldigoxin; 4'''-Acetyldigoxin; Digoxigenin Tridigitoxoside-?-acetate; Novodigal;?-Acetyl Digoxin
Digoxin Impurity J is a fully characterized chemical compound used as a reference standard of API Digoxin. The standard offered is compliant with regulatory guidelines. Digoxin Impurity J is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 5355-48-6
